Once-weekly steroid dosing can promote muscle repair without atrophy

May 8, 2017, JCI Journals

Glucocorticoid steroids are used to treat a variety of conditions, including chronic inflammatory diseases and autoimmune diseases. Their effects on muscle recovery and repair make them particularly effective therapies for muscle injury and muscular dystrophies. However, chronic systemic exposure to glucocorticoid steroids also accelerates the breakdown of muscle tissue, which can lead to muscle wasting and weakness after long-term use.

In this issue of the JCI, a study led by Elizabeth McNally at Northwestern University's Feinberg School of Medicine reports that some unwanted side effects of glucocorticoid steroids might be avoided by reducing the frequency of the treatment regimen. In a mouse model of Duchenne muscular dystrophy and in normal mice, both daily and weekly steroid dosing improved the rate of from injury.

However, daily dosing also led to muscle atrophy that counteracted the benefits of enhanced muscle repair. In contrast, mice that received a once-weekly treatment with glucocorticoid steroids experienced improvements in muscle function and pathology that were not compromised by muscle atrophy.

The findings of this study suggest that reducing the frequency of glucocorticoid dosing may prevent their debilitating side effects while preserving therapeutic effects on . Further work is needed to determine how intermittent dosing regimens affect glucocorticoid therapies in human disease.

Explore further: New target may slow disease progression in Duchenne muscular dystrophy

More information: Mattia Quattrocelli et al, Intermittent glucocorticoid steroid dosing enhances muscle repair withouteliciting muscle atrophy, Journal of Clinical Investigation (2017). DOI: 10.1172/JCI91445

Related Stories

New target may slow disease progression in Duchenne muscular dystrophy

September 12, 2016
Duchenne muscular dystrophy is a chronic disease causing severe muscle degeneration that is ultimately fatal. As the disease progresses, muscle precursor cells lose the ability to create new musclar tissue, leading to faster ...

Keratin hydrogels show significant potential to regenerate lost muscle tissue and function

April 27, 2017
The use of human hair-derived keratin biomaterials to regenerate skeletal muscle has shown promise in new research that documents significant increases in both new muscle tissue formation and muscle function among mouse models ...

Side-effects of anti-inflammatory steroids could be prevented, research finds

June 9, 2014
(Medical Xpress)—Problem side effects including high blood pressure, obesity, muscle wasting, osteoporosis and skin thinning in arthritis and asthma sufferers who take a certain kind of steroid could be prevented by deleting ...

Gene identified that produces benefits of steroids, without the detrimental side effects

November 23, 2015
Scientists have revealed that glucocorticoids, a class of steroid hormones that are commonly prescribed as drugs, enhance muscle endurance and alleviate muscular dystrophy through activation of the gene KLF15. Critically, ...

Study identifies potential drug targets for muscular dystrophy treatments

January 9, 2017
Myotonic dystrophy type I (MD1) is a common form of muscular dystrophy associated with muscle wasting, weakness, and myotonia. These symptoms are linked to the accumulation of toxic gene transcripts in muscle cells that result ...

Muscular dystrophy: Repair the muscles, not the genetic defect

September 14, 2014
A potential way to treat muscular dystrophy directly targets muscle repair instead of the underlying genetic defect that usually leads to the disease.

Recommended for you

Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model

July 20, 2018
Wrinkled skin and hair loss are hallmarks of aging. What if they could be reversed?

Breakthrough could impact cancer, ageing and heart disease

July 20, 2018
A team of Sydney scientists has made a groundbreaking discovery in telomere biology, with implications for conditions ranging from cancer to ageing and heart disease. The research project was led by Dr. Tony Cesare, Head ...

Enzyme identified as possible novel drug target for sickle cell disease, Thalassemia

July 19, 2018
Medical researchers have identified a key signaling protein that regulates hemoglobin production in red blood cells, offering a possible target for a future innovative drug to treat sickle cell disease (SCD). Experiments ...

Mice given metabolite succinate found to lose weight by turning up the heat

July 19, 2018
A team of researchers with members from institutions across the U.S. and Canada has found that giving the metabolite succinate to mice fed a high-fat diet prevented obesity. In their paper published in the journal Nature, ...

Supplement may ease the pain of sickle cell disease

July 19, 2018
(HealthDay)—An FDA-approved supplement reduces episodes of severe pain in people with sickle cell disease, a new clinical trial shows.

Scientists uncover DNA 'shield' with crucial roles in normal cell division

July 18, 2018
Scientists have made a major discovery about how cells repair broken strands of DNA that could have huge implications for the treatment of cancer.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.